Skip to main content
. 2021 Aug 10;5(5):811–816. doi: 10.1016/j.mayocpiqo.2021.07.001

Figure 2.

Figure 2

Validation of international normalized ratio (INR) among pediatric patients receiving warfarin therapy at high risk for thrombotic complications. CFX, chromogenic factor X.